In the OM-GHD group, 17 patients (48.6%) had serum IGF-1 levels < −2 SDS, 14 patients (40%) were between −2 and 0 SDS, and 4 patients (11.4%) had values of IGF-1 > 0 SDS. This evidence concerns the gene IGF1 and ocular melanoma.